poisar

Stocks · News reference

FDA Approves Kenvue’s TYLENOL With Naproxen, OTC Fixed-Dose Combination Of Acetaminophen And Naproxen Sodium

Jul 24, 2026, 6:05 PMBenzinga Newsdesk

TYLENOL® with Naproxen is a clinically proven, opioid-free, fixed-dose combination that begins working in under 30 minutes and provides 12 hours of pain relief in a single dose.FDA-approved first and only OTC fixed‑dose

Read original sourceMore stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

KVUE
Source
benzinga
Observed
Jul 24, 2026, 6:05 PM
Checked
Jul 24, 2026, 6:05 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Aug 24, 2026, 3:30 PMMatt Dilallo

    This Consumer Staples Giant's Dividend Streak Rivals PepsiCo. Nobody Talks About It.

    Kimberly-Clark is an overlooked Dividend King with a 54-year consecutive dividend increase streak matching PepsiCo's. Despite lower brand recognition, KMB offers a higher yield (4.7% vs 4.1%), more resilient demand for household products, and is acquiring Kenvue to enhance its global portfolio, making it an attractive option for income-focused investors.

    Read original at the-motley-fool
    KMBPEPKVUE